Actinium Pharmaceuticals, Inc. (ATNM) Earnings
|
Expand Research on ATNM
| Next EPS Date | 11/23/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -47.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/23/26  |
Q326 | N/A | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/24/26 |
Q226 | N/A | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/17/26 |
Q226 | N/A | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/3/26 |
Q226 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/31/26 |
Q226 | N/A | -$0.21 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/21/26 |
Q126 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/18/26 |
Q126 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/19/26 |
Q126 | N/A | -$0.22 | N/A | N/A | N/A | N/A | N/A | N/A |
